Records containing: Lymphoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2012-03-15A Phase I Study Of 17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17DMAG) With Evaluation Of Hsp90 Client Proteins In Subjects With Solid Tumors And Lymphomas
-
CLINICAL_TRIALS study record update · 2012-03-15A Multidose Phase I Study of Oral CC5013, a Thalidomide Derivative, in Patients With Refractory Metastatic Cancer
-
CLINICAL_TRIALS study record update · 2012-03-15A Phase 0 Pharmacokinetic, Pharmacodynamic Study of ABT-888, an Inhibitor of Poly (ADP-ribose) Polymerase (PARP), in Refractory Solid Tumors and Lymphoid Malignancies
-
CLINICAL_TRIALS study record update · 2012-03-15A PHASE I STUDY OF THE COMBINATION OF CAI AND PACLITAXEL IN ADULT PATIENTS WITH REFRACTORY CANCERS OR LYMPHOMA
-
CLINICAL_TRIALS study record update · 2012-03-15Characterization of Serum Proteomic Patterns in Neoplastic and Inflammatory Skin Disease
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2012-03-15Telomerase Activity Of CD34+ Cells - Marker For Mobilization Quality And Predictor For Engraftment After Autologous Hematopoietic Cell Transplantation
-
CLINICAL_TRIALS study record update · 2012-03-15A Phase II Clinical Trial of 17-(Allylamino)-17- Demethoxygeldanamycin (17-AAG, NSC 330507 and EPL Diluent, NSC 704057) in Adults With Systemic Mastocytosis
-
CLINICAL_TRIALS study record update · 2012-03-15A Pilot Study of Unrelated Umbilical Cord Blood Transplantation in Patients With High Risk Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2012-03-15Survival in Allogeneic Bone Marrow Transplantation: The Relative Importance of Inpatient Lay Care-Partner Support
-
CLINICAL_TRIALS study record update · 2012-03-15Pathogenesis And Course Of Cutaneous T-Cell Lymphoma
-
CLINICAL_TRIALS study record update · 2012-03-08T-Cell Depleted, Reduced-Intensity Allogeneic Stem Cell Transplantation From Haploidentical Related Donors For Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2012-03-08Assessing Implementation and Effectiveness of Individual Education Plans for Children With Chronic Illness
-
CLINICAL_TRIALS study record update · 2012-03-08Phase I Trial of Fenretinide (4-HPR, NSC 374551) Lym-X-Sorb™ (LXS) Oral Powder (4-HPR/LXS Oral Powder) (4-HPR) in Adults With Solid Tumors and Lymphomas
-
CLINICAL_TRIALS study record update · 2012-03-08A Phase I-II Safety, Tolerability And Pharmacokinetic Study Of Ravuconazole For Prophylaxis Of Invasive Fungal Infections In Patients Undergoing Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2012-03-06An Open-Label, Randomized, Phase 3 Trial Of Intravenous Temsirolimus (CCI-779) At Two Dose Levels Compared To Investigator's Choice Therapy In Relapsed, Refractory Subjects With Mantle Cell Lymphoma (MCL)
-
CLINICAL_TRIALS study record update · 2012-03-05Cognitive Functioning and Quality of Life in CNS Lymphoma
-
CLINICAL_TRIALS study record update · 2012-02-28A Phase I, Dose Escalation Trial of Recombinant Modified Vaccinia Ankara (MVA)-Based Vaccine Encoding Epstein-Barr Virus Target Antigens
-
CLINICAL_TRIALS study record update · 2012-02-24Molecular Epidemiology of Lymphoma Patients
-
CLINICAL_TRIALS study record update · 2012-02-20PILOT MULTINATIONAL PROTOCOLS IN ACUTE LYMPHOBLASTIC LEUKEMIA AND DIFFUSE NON-HODGKIN'S LYMPHOMA
-
CLINICAL_TRIALS study record update · 2012-02-20Phase II Study of L-asparaginase Monotherapy as Salvage Treatment in Patients With NK/T Cell Lymphoma
-
CLINICAL_TRIALS study record update · 2012-02-20Phase II Study of L-asparaginase Plus DICE Regimen in Patients With Stage I/II NK/T-cell Lymphoma
-
CLINICAL_TRIALS study record update · 2012-02-20Phase II Study of Rituximab Combined With ESHAP in Patients With Relapse or Refractory DLBCL
-
CLINICAL_TRIALS study record update · 2012-02-20Phase II Study of ATRAGEN (Liposomal Tretinoin) in Patients With Relapsed or Refractory Hodgkin's Disease
-
CLINICAL_TRIALS study record update · 2012-02-14An Open-label Multi-dose-escalation, Safety and Pharmacokinetic Study of SAR3419 Administered as a Single Agent by Intravenous Infusion Every 3 Weeks in Patients With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma (NHL)
-
CLINICAL_TRIALS study record update · 2012-02-13Randomized Trial Using Standard Dose Versus High Dose Rituximab in Addition to Autologous Transplantation With BEAM for Patients With Diffuse Large B Cell Lymphomas